Skip to main content
Erschienen in: International Urology and Nephrology 4/2009

01.12.2009 | Nephrology - Original Paper

Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006

verfasst von: Ferhat Catal, Nuket Bavbek, Omer Bayrak, Musemma Karabel, Duran Karabel, Ender Odemis, Ebru Uz

Erschienen in: International Urology and Nephrology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Objective

In patients with suspected urinary tract infection (UTI), antibiotic treatment is usually started empirically, before urine culture results are available. Unfortunately, antibiotic resistance has become an increasingly pressing clinical issue in many countries. The objective of this study was to assess the changing susceptibility of urinary pathogens to commonly used antimicrobials in a six-year period to evaluate the options for empirical antibiotic therapy in children with community acquired UTI.

Material and methods

A retrospective analysis of data from all pediatric urine samples processed at Fatih University Medical School microbiology laboratory was undertaken for a period of six years (January 2000–December 2006).

Results

A total of 767 urinary pathogens were isolated from 767 episodes of UTI in 698 patients. The most common causative agent was Escherichia coli (E. coli) followed by Klebsiella spp. and others. In 2000 almost 60% of the E. coli isolates were susceptible to ampicillin (AMP), more than 40% to Co-trimoxazole (SXT), more than 80% to gentamicin (GN), more than 90% to cefuroxime (CXM) and amikacin (AN), and more than 60% to piperacillin (PIP). By 2006 more than 70% were resistant to AMP and more than 50% were resistant to PIP. In 2000 CIP (2.7% resistant isolates) and CXM (3.4% resistant isolates) were the most active agents against Klebsiella spp.; and none of the isolates was found to be resistant to imipenem (IMP). In 2006 GN (2.7% resistant isolates), CIP (3.5% resistant isolates), CXM (2.7% resistant isolates), and AN (8.9% resistant isolates) were the most active agents against these species and still no resistance to IMP was found. For E. Coli the increase in resistance to AMP, CTX, IMP, and PIP was statistically significant (P < 0.05). For Klebsiella spp. the increase in resistance to AMP and CXM was statistically significant (P < 0.05).

Conclusions

Empirical antibiotic selection should be based on knowledge of the local prevalence of bacterial organisms and antibiotic sensitivities, because resistance patterns may vary in different regions.
Literatur
1.
Zurück zum Zitat Elder JS (2000) Urologic disorders in infants and children. In: Behrman RE, Kliegman RM, Jenson HB (eds) Nelson textbook of pediatrics, 16th edn. WB Saunders, Philadelphia, pp 1621–1625 Elder JS (2000) Urologic disorders in infants and children. In: Behrman RE, Kliegman RM, Jenson HB (eds) Nelson textbook of pediatrics, 16th edn. WB Saunders, Philadelphia, pp 1621–1625
3.
Zurück zum Zitat Allen UD, MacDonald N et al (1999) Risk factors for resistance to ‘first-line’ antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 160:1436–1440PubMed Allen UD, MacDonald N et al (1999) Risk factors for resistance to ‘first-line’ antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 160:1436–1440PubMed
6.
Zurück zum Zitat National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Approved Standard. M100-S12. NCCLS, Wayne, PA National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Approved Standard. M100-S12. NCCLS, Wayne, PA
8.
Zurück zum Zitat Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB (1999) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 44:359–365. doi:10.1093/jac/44.3.359 CrossRefPubMed Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB (1999) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 44:359–365. doi:10.​1093/​jac/​44.​3.​359 CrossRefPubMed
9.
Zurück zum Zitat Beunders AJ (1994) Development of antibacterial resistance. The Dutch experience. J Antimicrob Chemother 33:17–22PubMed Beunders AJ (1994) Development of antibacterial resistance. The Dutch experience. J Antimicrob Chemother 33:17–22PubMed
10.
12.
Zurück zum Zitat Weber G, Riesenberg K et al (1997) Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991–1995. Eur J Clin Microbiol Infect Dis 16:834–835. doi:10.1007/BF01700414 CrossRefPubMed Weber G, Riesenberg K et al (1997) Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991–1995. Eur J Clin Microbiol Infect Dis 16:834–835. doi:10.​1007/​BF01700414 CrossRefPubMed
15.
Zurück zum Zitat Bronzwaer SL, Cars O, and participants in the European Antimicrobial Surveillance System et al (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278–282CrossRefPubMed Bronzwaer SL, Cars O, and participants in the European Antimicrobial Surveillance System et al (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278–282CrossRefPubMed
18.
Zurück zum Zitat Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH (2000) Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 21:455–458. doi:10.1086/501787 CrossRefPubMed Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH (2000) Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 21:455–458. doi:10.​1086/​501787 CrossRefPubMed
19.
Zurück zum Zitat Toltzis P, Dul M et al (2003) Cefepime use in pediatric intensive care unit reduces colonization with resistant bacilli. Pediatr Infect Dis J 22:109–114PubMed Toltzis P, Dul M et al (2003) Cefepime use in pediatric intensive care unit reduces colonization with resistant bacilli. Pediatr Infect Dis J 22:109–114PubMed
21.
Zurück zum Zitat Goldmann DA, Weinstein RA et al (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. Workshop to Prevent, Control the Emergence, Spread of Antimicrobial-Resistant Microorganisms in Hospitals. JAMA 275:234–240. doi:10.1001/jama.275.3.234 CrossRefPubMed Goldmann DA, Weinstein RA et al (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. Workshop to Prevent, Control the Emergence, Spread of Antimicrobial-Resistant Microorganisms in Hospitals. JAMA 275:234–240. doi:10.​1001/​jama.​275.​3.​234 CrossRefPubMed
Metadaten
Titel
Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006
verfasst von
Ferhat Catal
Nuket Bavbek
Omer Bayrak
Musemma Karabel
Duran Karabel
Ender Odemis
Ebru Uz
Publikationsdatum
01.12.2009
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 4/2009
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-008-9445-5

Weitere Artikel der Ausgabe 4/2009

International Urology and Nephrology 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.